Universal Health Services Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $18.1B+14.4% YoYTTM through 30 Jun 2026
Net Income $1.5B+33.6% YoYTTM through 30 Jun 2026
Free Cash Flow $845.4MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| EBITDA Margin | 14.9% |
| Operating Margin | 11.2% |
| Net Margin | 8.4% |
Returns
20.3%ROE
9.6%ROA
12.5%ROIC
Balance Sheet Health
Debt / Equity0.63x
Current Ratio1.12x
Net Debt$4.6B
Cash & Equivalents$138.8M
Quality Metrics
Altman Z-Score3.05
Piotroski F-Score7 / 9
FCF Margin4.7%
Rule of 407.4
Earnings-Beat Rate75.0%
Multi-Year Trend
RevenueFY2025: $17.4B
Diluted EPS$24.50TTMFY2025: $23.10
Dividend
$0.40Per share, FY20260.22%Yield-12.9%5-yr growth
Capital Allocation
Capex Intensity5.3%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Acute Care Hospital Services | +8.2% | View detailsUHS expects full-year 2026 adjusted admissions to grow by 2% to 3% compared to 2025, with the majority of the growth anticipated in the second half of the year. | |
| Behavioral Health Care Services | +7.3% | View detailsUHS targets long-term growth of 2% to 3% in adjusted patient days for the behavioral segment, supported by staffing additions and strong outpatient demand. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.